Skip to main content
. 2018 May;10(5):2631–2637. doi: 10.21037/jtd.2018.04.125

Table 3. Comparison of EGFR/KRAS/ALK mutations between 30 thoracic biopsy specimens detected by ARMS and matched pleural effusion specimens detected by NGS.

Pleural effusion specimen (NGS) Thoracic biopsy specimen (ARMS)
+ Total
+ 24 2 26
2 2 4
Total 26 4 30

+, EGFR/KRAS/ALK positive mutation; −, EGFR/KRAS/ALK negative mutation. NGS, next-generation sequencing.